First Trust NYSE Arca Biotechnology Index Fund(FBT)

Pre275.296.33+2.35%08:35 EDT
268.96-1.99-0.73%

Market data delayed 15 minutes

    • CC on ETFs
      ·
      03-26

      Biotech Surges: Which ETFs Are Worth Watching?

      Yesterday, the U.S. biotech sector showed strong momentum, with the $纳斯达克生物技术指数(NBI)$ rising 2.64% in a single day. From a structural perspective, gains were broadly distributed across small- and mid-cap innovative drug companies, with $Sarepta Therapeutics(SRPT)$ surging nearly 35% and multiple names such as $Arrowhead Research Corporation(ARWR)$ and $Arvinas Holding Company LLC(ARVN)$ rising more than 5%, indicating a clear breadth-driven rally. From a one-day performance perspective, biotech-related ETFs moved higher across the board, with stronger gains in innovative and high-beta segments.
      Biotech Surges: Which ETFs Are Worth Watching?
      TOPfloopi: SBIO's looking tops for a punt, mate![强]
      1
      Report
      orsiri
      ·
      2024-05-09

      The Biotech Buzz: and the Allure of SPDR S&P Biotech ETF (XBI)

      Ah, the captivating world of biotech investments, where fortunes can bloom like genetically modified crops or wither like last season's kale. Let's plunge into the enticing depths of the SPDR S&P Biotech ETF ($Spdr S&P Biotech Etf(XBI)$) and unearth its hidden treasures. Performance and Market Trends XBI's historical price movements Picture this: XBI struts its stuff with a dashing 11.74% surge over the past year, outperforming many of its peers in the biotech ETF realm. To put this into perspective, let's compare it to the broader market represented by the S&P 500 Index, which recorded a 7% gain over the same period. This indicates XBI's robust performance in a sector known for its volatility. In 2024, it's already up by a cheeky 3.56%
      The Biotech Buzz: and the Allure of SPDR S&P Biotech ETF (XBI)
      1
      Report
      ETF_Tracker
      ·
      2023-12-31

      Biotech Industry Resurgence: Anticipating New Trends and Bright Prospects in 2024

      The biotechnology industry is experiencing a revival, breaking free from a period of stagnation.Since reaching its peak in early 2021, the S&P Biotechnology Select Industry Index has lost over 50% of its value. The downturn can be attributed to rising interest rates and a slowdown in the success of the pandemic period, leading to a widespread pessimism among investors.Looking ahead to 2024, analysts anticipate a more favorable interest rate environment, increased deal activity, and innovations in critical areas such as cancer and immunology, brightening the prospects for biotechnology companies. The biotech industry's index has seen a 29% increase since the end of October.Merger and acquisition activities in the biotech industry are gaining momentum. According to PwC's latest analysis,
      Biotech Industry Resurgence: Anticipating New Trends and Bright Prospects in 2024
      TOPLmBeats: But I am going back in a little while and then I'll come home 🏡 I just don't have the energy right at
      21
      Report
      ETF_Tracker
      ·
      2023-09-27

      ETF Tracker | What Is a Biotech ETF? Investing in Innovative Healthcare Technology

      Biotech ETFs offer investors a convenient way to gain exposure to the dynamic and innovative biotechnology sector without the need to individually select and manage biotech stocks. These specialty healthcare funds may be attractive to investors who are interested in participating in the growth and advancements of biotech companies and the potential for breakthrough medical treatments. What Is a Biotech ETF? A biotech ETF is an exchange-traded fund that is specifically designed to track the performance of companies within the biotechnology sub-sector within the broader healthcare sector. Biotechnology companies focus on the use of biological processes, organisms and systems to develop new products and technologies, with a particular emphasis on medical and pharmaceutical
      ETF Tracker | What Is a Biotech ETF? Investing in Innovative Healthcare Technology
      Comment
      Report
    • Company Profile

      Company Name
      First Trust NYSE Arca Biotechnology Index Fund
      Market
      ARCA
      Establishment Date
      - -
      Employees
      - -
      Office Location
      - -
      Zip Code
      - -
      Phone
      - -
      Fax
      - -
      Introduction
      The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
      • 1D
      • 5D
      • Day
      • Week
      • Month

      Loading ...

      High
      269.70
      Open
      269.17
      Volume%
      4.25
      Low
      267.28
      Close
      270.95
      T/O Rate
      1.75%
       
       
       
       

      Most Discussed